Systagenix, An Acelity Company

Systagenix is now an Acelity company! Acelity is a global market leader in advanced wound therapeutics and regenerative medicine, offering innovative solutions from the hospital to home that improve the lives of patients in more than 80 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients’ lives. We are the undisputed leader in negative pressure wound therapy, the number one provider of regenerative tissue products used for breast reconstruction and hernia repair, and the market leader in collagen dressings. Acelity is headquartered in San Antonio, Texas, with more than 5,800 employees around the globe. Systagenix was formed through the acquisition of Johnson & Johnson’s advanced wound care business in 2008. Our longstanding commitment to skin and wound care began with innovative wound care products developed by the experienced team of R&D Scientists at the Gargrave Centre of Excellence for Wound Healing in North Yorkshire. Systagenix leading edge product portfolio includes ADAPTIC TOUCH®, TIELLE®, SILVERCEL® NON-ADHERENT, ACTISORB®, INADINE®, PROMOGRAN®, and PROMOGRAN PRISMA®.